Clinical information for analysis included DE-mRNA signature, age, PFI status, mutational status of BRAF V600E, RAS, RET, NTRK1, and TERT, sex, histological subtype, T stage, N stage, M stage, AJCC stage, residual tumor status, extrathyroidal extension, multifocality, and anatomic site. This evidence concerns the gene RET and neoplasm.